Abstract
Efavirenz is an anti-HIV drug categorized under Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). It is recognized as the first line drug of choice for treating HIV infections. Poor aqueous solubility of the drug (< 10 µg/mL) offers specific challenges in formulation design, leading to limited bioavailability of 40 to 50%. To address this issue, several drug delivery options have been adopted for Efavirenz with special emphasis on alternative routes of administration like buccal, rectal, vaginal and transdermal. The carrier-based delivery using vesicular systems, micro/nanoparticles, hydrogels, degradable systems, etc. was also designed through solvent evaporation, spray drying, double emulsification and ionic gelation techniques. The nanotechnology-based drug delivery approaches have been demonstrated with significant improvement in the solubility and bioavailability of Efavirenz. The objective of the review is to compile and present the comprehensive report of various researches highlighted for synthesizing nanoparticles of Efavirenz using different polymeric and nonpolymeric materials. We have discussed the range of materials utilized for the preparation of stable nanoparticles through the validated experimental protocol and their substantial selection of optimized formulation through significant results.
Keywords: Efavirenz, dissolution, solubility, nanoparticles, polymer, HIV.
Current Organic Chemistry
Title:Effect of Nanotechnology Approaches on Anti-retroviral Molecule: Efavirenz
Volume: 22 Issue: 27
Author(s): K. Priya Dharshini, D. Ramya Devi and B.N. Vedha Hari*
Affiliation:
- Department of Pharmacy, School of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur- 613401,India
Keywords: Efavirenz, dissolution, solubility, nanoparticles, polymer, HIV.
Abstract: Efavirenz is an anti-HIV drug categorized under Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). It is recognized as the first line drug of choice for treating HIV infections. Poor aqueous solubility of the drug (< 10 µg/mL) offers specific challenges in formulation design, leading to limited bioavailability of 40 to 50%. To address this issue, several drug delivery options have been adopted for Efavirenz with special emphasis on alternative routes of administration like buccal, rectal, vaginal and transdermal. The carrier-based delivery using vesicular systems, micro/nanoparticles, hydrogels, degradable systems, etc. was also designed through solvent evaporation, spray drying, double emulsification and ionic gelation techniques. The nanotechnology-based drug delivery approaches have been demonstrated with significant improvement in the solubility and bioavailability of Efavirenz. The objective of the review is to compile and present the comprehensive report of various researches highlighted for synthesizing nanoparticles of Efavirenz using different polymeric and nonpolymeric materials. We have discussed the range of materials utilized for the preparation of stable nanoparticles through the validated experimental protocol and their substantial selection of optimized formulation through significant results.
Export Options
About this article
Cite this article as:
Dharshini Priya K. , Devi Ramya D. and Hari Vedha B.N.*, Effect of Nanotechnology Approaches on Anti-retroviral Molecule: Efavirenz, Current Organic Chemistry 2018; 22 (27) . https://dx.doi.org/10.2174/1385272822666181116122616
DOI https://dx.doi.org/10.2174/1385272822666181116122616 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Phentermine and Topiramate Extended-Release for the Obesity: New Kids on the Block
Recent Patents on Cardiovascular Drug Discovery NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer's Disease
Current Drug Discovery Technologies Transcranial Magnetic Stimulation on Rodent Models
CNS & Neurological Disorders - Drug Targets Lower Uric Acid Linked with Cognitive Dysfunction in the Elderly
CNS & Neurological Disorders - Drug Targets Host Neuro- Immuno-Endocrine Responses In Periodontal Disease
Current Pharmaceutical Design Pharmacogenetics and Pharmagenomics, Trends in Normal and Pathological Aging Studies: Focus on p53
Current Pharmaceutical Design Editorial [ Proteases and Phospholipases in CNS Disorders Guest Editor: Swapan K. Ray ]
CNS & Neurological Disorders - Drug Targets The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Anti-Cancer Agents in Medicinal Chemistry Omega-3 Fatty Acids and their Role in Central Nervous System - A Review
Current Medicinal Chemistry Huntingtons Disease: New Frontiers for Molecular and Cell Therapy
Current Drug Targets The Role of EC-IC Bypass in Critical Cerebral Hemodynamics of Different Origin
Current Hypertension Reviews Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Other Anti- Inflammatory Agents in the Treatment of Neurodegenerative Disease
Current Alzheimer Research Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders
Current Topics in Medicinal Chemistry Neurobiology of Sleep Fragmentation: Cortical and Autonomic Markers of Sleep Disorders
Current Pharmaceutical Design Extraction, Characterization and In Vivo Neuromodulatory Activity of Phytosterols from Microalga Dunaliella Tertiolecta
Current Medicinal Chemistry Clozapine Safety, 40 Years Later
Current Drug Safety Metal-Protein Attenuating Compounds (MPACs) for the Treatment of Alzheimers Disease
Drug Design Reviews - Online (Discontinued) Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis
Current Alzheimer Research Neurogenesis in Alzheimers Disease: A Realistic Alternative to Neuronal Degeneration?
Current Signal Transduction Therapy Editorial: Spatial Cognition in Normal Aging, MCI and AD
Current Alzheimer Research